The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better! | Bentham Science
Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!

Author(s): Djordje S. Popovic, Theocharis Koufakis and Nikolaos Papanas*

Volume 21, Issue 4, 2023

Published on: 21 August, 2023

Page: [219 - 221] Pages: 3

DOI: 10.2174/1570161121666230817105105

Open Access Journals Promotions 2
Next »
[1]
Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014; 371(21): 1972-82.
[http://dx.doi.org/10.1056/NEJMoa1408214] [PMID: 25409370]
[2]
Svane J, Lynge TH, Pedersen-Bjergaard U, et al. Cause-specific mortality in children and young adults with diabetes mellitus: A Danish nationwide cohort study. Eur J Prev Cardiol 2021; 28(2): 159-65.
[http://dx.doi.org/10.1177/2047487319836550] [PMID: 30862235]
[3]
Jørgensen ME, Almdal TP, Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 2013; 56(11): 2401-4.
[http://dx.doi.org/10.1007/s00125-013-3025-7] [PMID: 23949580]
[4]
Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes 2012; 61(11): 2987-92.
[http://dx.doi.org/10.2337/db11-1625] [PMID: 22851572]
[5]
Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: Possible causes and implications. Circ Res 2017; 120(2): 366-80.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.309115] [PMID: 28104770]
[6]
Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017; 376(15): 1407-18.
[http://dx.doi.org/10.1056/NEJMoa1608664] [PMID: 28402770]
[7]
Hallström S, Wijkman MO, Ludvigsson J, et al. Risk factors, mortality trends, and cardiovascular diseases in people with type 1 diabetes and controls in Sweden: An observational cohort study. Lancet Reg Health Eur 2022; 21: 100469.
[http://dx.doi.org/10.1016/j.lanepe.2022.100469] [PMID: 35898332]
[8]
Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: A nationwide, register-based cohort study. Lancet 2018; 392(10146): 477-86.
[http://dx.doi.org/10.1016/S0140-6736(18)31506-X] [PMID: 30129464]
[9]
Ruiz PLD, Chen L, Morton JI, et al. Mortality trends in type 1 diabetes: A multicountry analysis of six population-based cohorts. Diabetologia 2022; 65(6): 964-72.
[http://dx.doi.org/10.1007/s00125-022-05659-9] [PMID: 35314870]
[10]
Vistisen D, Andersen GS, Hansen CS, et al. Prediction of first cardiovascular disease event in type 1 diabetes mellitus: The steno type 1 risk engine. Circulation 2016; 133(11): 1058-66.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018844] [PMID: 26888765]
[11]
Serés-Noriega T, Giménez M, Perea V, et al. Use of the Steno T1 Risk Engine identifies preclinical atherosclerosis better than use of ESC/EASD-2019 in adult subjects with type 1 diabetes at high risk. Diabetes Care 2022; 45(10): 2412-21.
[http://dx.doi.org/10.2337/dc22-0118] [PMID: 35944257]
[12]
Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41(2): 255-323.
[http://dx.doi.org/10.1093/eurheartj/ehz486] [PMID: 31497854]
[13]
Popovic DS, Stoian AP, Papanas N. Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus? J Diabetes Complications 2022; 36(11): 108338.
[http://dx.doi.org/10.1016/j.jdiacomp.2022.108338] [PMID: 36240667]
[14]
Popovic DS, Stoian AP, Papanas N. Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus? Endocrine 2023; 80(1): 232-3.
[http://dx.doi.org/10.1007/s12020-022-03294-3] [PMID: 36607508]

Rights & Permissions Print Cite
Article Metrics
28
2
Wayfinder Image
Open Access Journals Promotions
World Prematurity Day
© 2024 Bentham Science Publishers | Privacy Policy